The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPLZL.L Regulatory News (PLZL)

  • There is currently no data for PLZL

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Extension of Consent Solicitation

1 Jul 2022 17:23

RNS Number : 1051R
Polyus Finance PLC
01 July 2022
 

1 July 2022

Polyus Finance Plc announces extension of the Consent Solicitation for its outstanding U.S.$800,000,000 5.250% Guaranteed Notes due 2023, U.S.$500,000,000 4.70% Guaranteed Notes due 2024 and U.S.$700,000,000 3.25% Guaranteed Notes due 2028

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN OR INTO, OR TO ANY PERSON LOCATED OR RESIDENT IN, ANY JURISDICTION WHERE IT IS UNLAWFUL TO RELEASE, PUBLISH OR DISTRIBUTE THIS ANNOUNCEMENT OR THE MEMORANDUM.

On 24 June 2022, Polyus Finance Plc (the "Issuer") announced a consent solicitation (the "Consent Solicitation") in relation to the outstanding U.S.$800,000,000 5.250% Guaranteed Notes due 2023, U.S.$500,000,000 4.70% Guaranteed Notes due 2024 and U.S.$700,000,000 3.25% Guaranteed Notes due 2028 issued by the Issuer (the "Notes") on the terms and subject to the conditions set forth in the Consent Solicitation Memorandum dated 24 June 2022 (the "Memorandum"). Capitalised terms used in this announcement but not defined herein have the meanings given to them in the Memorandum.

The Issuer hereby notifies the Noteholders that it has decided to change the Record Date from 1 July 2022 to 13 July 2022 (the "New Record Date") and extend the Consent Deadline from 4 July 2022 (12:00 p.m. (London time)) to 14 July 2022 (5:00 p.m. (London time)) (subject to the right of the Issuer to extend, reopen, amend and/or terminate the Consent Solicitation, subject to applicable law and the provisions of the Trust Deed) (the "New Consent Deadline").

Amendments to the Consent Solicitation are limited to the New Record Date and the New Consent Deadline, as outlined above. All other terms of the Consent Solicitation will remain the same.

Noteholders who have already delivered Consent Instructions in the Consent Solicitation will not be deemed to have consented to the Proposals and will need to deliver new Consent Instructions in the Consent Solicitation providing proof of holding as of the New Record Date by no later than the New Consent Deadline.

Questions and requests for assistance in connection with the Consent Solicitation and in connection with delivery of Consent Instruction may be directed to the Information and Tabulation Agent.

Information and Tabulation Agent:

i2 Capital Markets Ltd

Kemp House, 160 City Road

London, ECV 2NX, United Kingdom

Email: info@i2capmark.com

Phone: +44 203 633 1212

Consent Solicitation Website: https://i2capmark.com/event-details/59/Holder/polyus-finance-plc

Questions and requests for assistance in connection with the Consent Solicitation may also be directed to the Investor Relations Department of PJSC Polyus.

PJSC Polyus

Investor Relations

3 bldg 1, Krasina St., Moscow, 123056, Russia

Email: ir@polyus.com

Phone: +7 495 641 33 77

 

DISCLAIMER

This announcement must be read in conjunction with the Memorandum. This announcement and the Memorandum contain important information which should be read carefully before any decision is made with respect to the Consent Solicitation. If any Noteholder is in any doubt as to the action it should take or is unsure of the impact of its participation in the Consent Solicitation, it is recommended to seek its own financial advice, including in respect of any tax consequences, immediately from its stockbroker, bank manager, solicitor, accountant or other independent financial or legal adviser. Any individual or company whose Notes are held on its behalf by a broker, dealer, bank, custodian, trust company or other nominee must contact such entity if it wishes to participate in the Consent Solicitation.

None of the Issuer, the Guarantors, the Trustee, the Information and Tabulation Agent or any director, officer, employee, agent or affiliate of any such person, is acting for any Noteholder, or will be responsible to any Noteholder for providing any protections which would be afforded to its clients or for providing advice in relation to the Consent Solicitation, and accordingly none of the Issuer, the Guarantors, the Trustee, the Information and Tabulation Agent or their respective directors, officers, employees, affiliates, advisers or agents makes any recommendation as to whether Noteholders should provide Consent, or refrain from taking any action in the Consent Solicitation with respect to their Notes, and none of them has authorised any person to make such recommendation. The Information and Tabulation Agent is agent of the Issuer and owe no duty to any Noteholder.

The Consents are only being solicited pursuant to the Memorandum and only in such jurisdictions as is permitted under applicable law.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCUAUNRUAUBRAR
Date   Source Headline
7th Jun 20223:41 pmRNSEGM results
13th May 20226:00 pmRNSChanges in shareholder structure
13th May 20222:35 pmRNSUpdate on LSE listing
12th May 20221:08 pmRNSNominations to the interim Board of Directors
29th Apr 20225:25 pmRNSAnnual Review
25th Apr 20222:26 pmRNSUpdate on operational and financial results
14th Apr 20221:14 pmEQSPOLYUS PJSC: Notice of EGM
11th Apr 20224:05 pmRNSChanges in senior management
6th Apr 202212:31 pmRNSChanges in shareholder structure
4th Apr 202211:40 amRNSFitch withdraws Polyus Finance Plc credit rating
4th Apr 202211:30 amRNSFitch withdraws PJSC Polyus credit rating
1st Apr 20225:11 pmRNSS&P lowers and withdraws Polyus credit rating
31st Mar 20224:45 pmRNSMoody’s withdraws Polyus Finance Plc credit rating
31st Mar 20224:29 pmRNSMoody’s withdraws PJSC Polyus credit rating
30th Mar 20221:03 pmRNSRepayment of Eurobond due 28 March 2022
23rd Mar 20224:31 pmRNSCorporate Update
23rd Mar 20224:23 pmRNSDirector/PDMR Shareholding
14th Mar 202212:49 pmRNSFitch downgrades PJSC Polyus rating
11th Mar 202211:34 amRNSMoody’s downgrades PJSC Polyus rating
9th Mar 20223:43 pmRNSChanges to the Board of Directors
9th Mar 20222:26 pmRNSConference call cancellation - replacement
9th Mar 20221:14 pmRNSS&P downgrades PJSC Polyus rating
7th Mar 20227:00 amRNSMSCI ESG Rating downgrades PJSC Polyus rating
7th Mar 20227:00 amRNSFitch downgrades PJSC Polyus rating to ‘B’
4th Mar 20223:37 pmRNSPJSC Polyus reports acquisition of shares
2nd Mar 20224:36 pmRNSPrice Monitoring Extension
2nd Mar 20222:09 pmRNSDirector/PDMR Shareholding
1st Mar 20224:43 pmRNSSecond Price Monitoring Extn
1st Mar 20224:38 pmRNSPrice Monitoring Extension
1st Mar 20227:00 amRNSFinancial results for 4Q and full year 2021
28th Feb 202210:54 amRNSNotice of Results – replacement
25th Feb 20222:37 pmRNSNotice of financial results for 4Q and 2021
8th Feb 20227:00 amRNSTrading update for 4Q 2021 and full year 2021
31st Jan 20224:51 pmRNSAnnounces launch of a buyback programme
30th Dec 20212:29 pmRNSDirector/PDMR Shareholding
23rd Nov 20217:00 amRNSFinancial results for the third quarter of 2021
18th Nov 20219:59 amRNSESG ratings and rankings update
17th Nov 202111:45 amRNSNotice of 3Q 2021 financial results
28th Oct 20214:00 pmRNSDirector/PDMR Shareholding
28th Oct 20217:00 amRNSTrading update for the third quarter of 2021
22nd Oct 20214:38 pmRNSDirector/PDMR Shareholding
14th Oct 20214:18 pmRNSClosing of USD 700 million Eurobonds offering
14th Oct 20214:03 pmRNSClosing of USD 700 million Eurobonds offering
8th Oct 202111:40 amRNSExpert RA raises Polyus credit rating to ‘ruAAA’
8th Oct 20218:28 amRNSResults of the capped tender offer
8th Oct 20218:19 amRNSResults of the capped tender offer
7th Oct 20219:12 amRNSINDICATIVE RESULTS OF THE CAPPED TENDER OFFER
7th Oct 20219:02 amRNSINDICATIVE RESULTS OF THE CAPPED TENDER OFFER
30th Sep 20212:12 pmRNSEGM results
28th Sep 202112:29 pmRNSTender offer for notes due 2022, 2023 and 2024

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.